Fowlpox virus infection causes a lymphoproliferative response in chickens

Viral Immunology

Volumn 16, Issue 2, 2003, Pages 223-227

  Singh, Pratik ^a   Tripathy, Deoki N ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; METHIONINE; RECOMBINANT VACCINE; SULFUR 35; VIRUS DNA; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; BIRD DISEASE; CELLULAR IMMUNITY; CHICKEN; CONTROLLED STUDY; FOWLPOX VIRUS; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALIA; AVES; DNA VIRUSES; FOWLPOX VIRUS; GALLUS GALLUS; MAMMALIA;

EID: 0038748048     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403322017956     Document Type: Article

References (26)

1. th World Poultry Diseases Conference, Montreal.
2. Beard, C.W., W.M. Schnitzlein, and D.N. Tripathy. 1991. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Dis. 35:356-359.
3. Boyle, D.B., and H.G. Heine. 1993. Recombinant fowlpox virus vaccines for poultry. Immunol. Cell. Biol. 71:391-397.
4. Cadoz, M., A. Strady, B. Meignier, et al. 1992. Immunisation with canarypox virus expressing rabies glycoprotein. Lancet 339:1429-1432.
5. Dharsana, R., and P.B. Spradbrow. 1985. The demonstration of cell-mediated immunity in chickens vaccinated with fowlpox virus. J. Vet. Med. B 32:628-632.
6. Edbauer C., R. Weinberg, J. Taylo, et al. 1990. Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase gene. Virology 179:901-904.
7. Karaca, K., J.M. Sharma, B.J. Winslow, et al. 1998. Recombinant fowlpox viruses co-expressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or posthatch administration of recombinant viruses. Vaccine 16:496-503.
8. Kent, S.J., A. Zhao, S.J. Best, et al. 1998. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:10180-10188.
9. Kent, S.J., A. Zhao, C.J. Dale, et al. 2000. A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques. Vaccine 18:2250-2256.
10. Lyles, D.S., C.C. Randall, L.G. Gafford, et al. 1976. Cellular fatty acids during fowlpox virus infection of three different host systems. Virology 70:227-229.
11. Marshall, J.L., M.J. Hawkins, K.Y. Tsang, et al. 1999. Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen. J. Clin. Oncol. 17:332-337.
12. Morita, C. 1973. Role of humoral and cell-mediated immunity in the recovery of chickens from fowlpox virus infection. J. Immunol. 3:1495-1501.
13. Nazerian, K., R.L. Witter, L.F. Lee, et al. 1996. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Dis. 40:368-376.
14. Pathak, P.N., G.V.S.V. Ramarao, and W.A.F. Tompkins. 1974. In vitro cellular immunity to unrelated pathogens in chickens infected with fowlpox virus. Infect. Immun. 1:34-41.
15. Rautenschlein, S., J.M. Sharma, B.J. Winslow, et al. 2000. Embryo vaccination of turkeys against Newcastle disease infection with recombinant fowlpox virus constructs containing interferons as adjuvants. Vaccine 18:426-433.
16. Razvi, E.S., and R.M. Welsh. 1995. Apoptosis in viral infections. Adv. Virus Res. 45:1-60.
17. Reddy, S.K., P. Singh, A. Silim, et al. 1998. Lymphopro-liferative responses of specific-pathogen-free chickens to a Mycoplasma gallisepticum strain, PG 31. Avian Pathol. 27:277-283.
18. Singh, P., and D.N. Tripathy. 2000. Characterization of monoclonal antibodies against fowlpox virus. Avian Dis. 44:365-371.
19. Singh, P., W.M. Schnitzlein, and D.N. Tripathy. 2003. Reticuloendotheliosis virus sequences within the genomes of field strains of fowlpox virus display variability. J. Virol. 77, 5855-5862.
20. Sprent, J., X. Zhang, S. Sun, et al. 2000. T-cell proliferation in vivo and the role of cytokines. Phil. Trans. R. Soc. Lond. B 355:317-322.
21. Staeheli, P., F. Puehler, K.C. Schneider, et al. 2001. Cytokines of birds; conserved function - a largely different look. J. Interferon Cytokine Res. 21:993-1010.
22. Tough, D.F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947-1950.
23. Tough, D.F., and J. Sprent. 1998. Bystander stimulation of T cells in vivo by cytokines. Vet. Immunol. Immunopathol. 63:123-129.
24. Tripathy, D.N., and W.M. Reed. 1997. Pox, pp. 643-659. In: B.W. Calnek, H.J. Barnes, C.W. Beard, et al. (eds.), Diseases of Poultry, 10th ed. Iowa State University Press, Ames, IA.
25. Tripathy, D.N., and W.M. Schnitzlein. 1991. Expression of avian influenza virus hemagglutinin by recombinant fowlpox virus. Avian Dis. 35:186-191.
26. Yu, L., W. Liu, W.M. Schnitzlein, et al. 2001. Study of protection by recombinant fowl poxvirus expressing C-terminal nucleocapsid protein of infectious bronchitis virus against challenge. Avian Dis. 45:340-348.